Intravenous corticosteroids to reduce gemtuzumab ozogamicin infusion reactions. [electronic resource]
Producer: 20031106Description: 1182-5 p. digitalISSN:- 1060-0280
- Acetaminophen -- adverse effects
- Adult
- Aminoglycosides
- Analgesics, Non-Narcotic -- adverse effects
- Anti-Bacterial Agents -- administration & dosage
- Anti-Inflammatory Agents -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Atrial Fibrillation -- chemically induced
- Chills -- chemically induced
- Dyspnea -- chemically induced
- Erythema -- chemically induced
- Fever -- chemically induced
- Gemtuzumab
- Hepatic Veno-Occlusive Disease -- chemically induced
- Humans
- Hypertension -- chemically induced
- Hypotension -- chemically induced
- Immunotoxins -- administration & dosage
- Infusions, Intravenous
- Leukemia, Myeloid, Acute -- drug therapy
- Methylprednisolone Hemisuccinate -- administration & dosage
- Pain -- chemically induced
- Rhabdomyolysis -- chemically induced
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.